Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 6

Results For "RAT"

9433 News Found

Fortis Bannerghatta launches SWARA Clinic for integrated voice, airway and swallowing care
Hospitals | April 16, 2026

Fortis Bannerghatta launches SWARA Clinic for integrated voice, airway and swallowing care

The new outpatient-focused clinic is designed to address voice, airway and swallowing disorders through advanced diagnostics


Healync Technologies secures Volrado Venture investment to build next-generation digital hospital infrastructure
Hospitals | April 15, 2026

Healync Technologies secures Volrado Venture investment to build next-generation digital hospital infrastructure

Funding to accelerate growth of concierge-style private health services and Aayu’s paperless hospital infrastructure platform


Novo Nordisk and OpenAI forge major AI alliance to accelerate drug discovery & healthcare operations
R&D | April 15, 2026

Novo Nordisk and OpenAI forge major AI alliance to accelerate drug discovery & healthcare operations

The collaboration will embed OpenAI’s advanced AI systems across Novo Nordisk’s global operations


Avantor India expands strategic collaboration with Parafilm to strengthen access to lab consumables
R&D | April 15, 2026

Avantor India expands strategic collaboration with Parafilm to strengthen access to lab consumables

Exclusive distribution pact with Amcor broadens access to Parafilm M sealing solutions for laboratories, horticulture and industrial users


MSN Laboratories launches SEMABEST, India-made semaglutide pen at nearly 50% lower price
Drug Approval | April 15, 2026

MSN Laboratories launches SEMABEST, India-made semaglutide pen at nearly 50% lower price

CDSCO-approved therapy enters India’s fast-growing post-patent GLP-1 market with fully integrated API, formulation and pen manufacturing


Pharma firms accelerate regional GLP-1 capacity to de-risk supply chains amid geopolitical tensions: GlobalData
News | April 14, 2026

Pharma firms accelerate regional GLP-1 capacity to de-risk supply chains amid geopolitical tensions: GlobalData

At the centre of this shift is Eli Lilly and Company, whose latest investments in China and Japan are helping redefine the next phase of GLP-1 supply strategy


AbbVie Phase 2 data show 62% response rate in ovarian cancer combo trial
Clinical Trials | April 14, 2026

AbbVie Phase 2 data show 62% response rate in ovarian cancer combo trial

Highlights Mirvetuximab-based regimen promise


GE HealthCare and Medtronic launch real-time brain surgery imaging integration
Technology | April 12, 2026

GE HealthCare and Medtronic launch real-time brain surgery imaging integration

The Stealth AXiS surgical navigation system was recently cleared by the US Food and Drug Administration (FDA) for cranial procedures in the United States


C4 Therapeutics and Roche launch bold push into next-generation cancer drug modality
News | April 12, 2026

C4 Therapeutics and Roche launch bold push into next-generation cancer drug modality

The partnership aims to fuse antibody-drug conjugation (ADC) technology with targeted protein degradation


Zydus improves ESG rating to 68, up from 66 last year
News | April 11, 2026

Zydus improves ESG rating to 68, up from 66 last year

The improved score reflects a stronger ESG profile for the Ahmedabad-based drugmaker